Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 10
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 503
Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 322
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 160
Mechanisms of viral inflammation and disease in humans
Jean‐Laurent Casanova, Laurent Abel
Science (2021) Vol. 374, Iss. 6571, pp. 1080-1086
Open Access | Times Cited: 121
The intersection of COVID-19 and autoimmunity
Jason S. Knight, Roberto Caricchio, Jean‐Laurent Casanova, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 111
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 111
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells
Rémi Planès, Miriam Pinilla, Karin Santoni, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2385-2400.e9
Open Access | Times Cited: 107
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 105
Human autoantibodies underlying infectious diseases
Anne Puel, Paul Bastard, Jacinta Bustamante, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 96
Specialized interferon action in COVID-19
Matthew D. Galbraith, Kohl T. Kinning, Kelly D. Sullivan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 83
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 80
Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 71
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tom Le Voyer, Audrey V. Parent, Xian Liu, et al.
Nature (2023) Vol. 623, Iss. 7988, pp. 803-813
Open Access | Times Cited: 65
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model
Katherine A. Waugh, Ross Minter, Jessica Baxter, et al.
Nature Genetics (2023) Vol. 55, Iss. 6, pp. 1034-1047
Open Access | Times Cited: 53
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 45
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 28
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 24
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
Catherine F. Hatton, Rachel A. Botting, María Emilia Dueñas, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 103
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic
C.J. Duncan, Morten Kelder Skouboe, Sophie Howarth, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 67
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Angélique Chauvineau‐Grenier, Paul Bastard, Antoine Servajean, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 459-470
Open Access | Times Cited: 66
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Paôline Laurent, Chao Yang, André F. Rendeiro, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 61
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19
Caspar I. van der Made, Mihai G. Netea, Frank L. van der Veerdonk, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19
Anna E. Spiering, Teun J. de Vries
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top